Tivantinib (ARQ 197) affects the apoptotic and proliferative machinery downstream of c-MET: role of Mcl-1, Bcl-xl and Cyclin B1-Reference-Cited by-同舟云学术

Tivantinib (ARQ 197) affects the apoptotic and proliferative machinery downstream of c-MET: role of Mcl-1, Bcl-xl and Cyclin B1

Published:2015-06-10 Issue:26 Volume:6 Page:22167-22178
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Lu Shuai¹,Török Helga-Paula¹,Gallmeier Eike²,Kolligs Frank T.¹³,Rizzani Antonia¹,Arena Sabrina⁴⁵,Göke Burkhard¹,Gerbes Alexander L.¹,De Toni Enrico N.¹

Affiliation:

1. Medizinische Klinik und Poliklinik 2, Klinikum der Universität München, Campus Grosshadern, Munich, Germany

2. Department of Gastroenterology, Endocrinology and Metabolism, University Hospital of Marburg, Philipps-University of Marburg, Marburg, Germany

3. Department of Internal Medicine and Gastroenterology, HELIOS Klinikum Berlin-Buch, Berlin, Germany

4. Department of Oncology, University of Torino, Candiolo, Torino, Italy

5. Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanistic study of dual‐function inhibitors targeting topoisomerase II and Rad51‐mediated DNA repair pathway against castration‐resistant prostate cancer;The Prostate;2023-08-15

2. Development of a MET-targeted single-chain antibody fragment as an anti-oncogene targeted therapy for breast cancer;Investigational New Drugs;2023-04

3. Development of a MET-targeted single-chain antibody fragment as an anti-oncogene targeted therapy for breast cancer;2022-11-02

4. Selective Inhibitor of the c-Met Receptor Tyrosine Kinase in Advanced Hepatocellular Carcinoma: No Beneficial Effect With the Use of Tivantinib?;Frontiers in Immunology;2021-11-02

5. Phenanthrotriazine Derivatives Containing Arylidine Hydrazone Moieties as Novel Potential c-Met Inhibitors with Anticancer Effect;IRAN J PHARM RES;2021